Stericycle (NASDAQ:SRCL) – Equities researchers at Barrington Research reduced their Q2 2018 EPS estimates for shares of Stericycle in a research report issued on Monday, May 14th. Barrington Research analyst K. Steinke now expects that the business services provider will post earnings of $1.09 per share for the quarter, down from their previous forecast of $1.12. Barrington Research currently has a “Buy” rating and a $75.00 target price on the stock. Barrington Research also issued estimates for Stericycle’s Q3 2018 earnings at $1.14 EPS, Q4 2018 earnings at $1.19 EPS, FY2018 earnings at $4.62 EPS and FY2019 earnings at $4.83 EPS.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, May 3rd. The business services provider reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.16. The firm had revenue of $895.00 million for the quarter, compared to the consensus estimate of $880.48 million. Stericycle had a net margin of 0.19% and a return on equity of 14.14%. The business’s quarterly revenue was up .3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.09 EPS.
Shares of Stericycle opened at $63.82 on Wednesday, according to Marketbeat.com. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.88. The stock has a market cap of $5.47 billion, a PE ratio of 14.71, a P/E/G ratio of 1.43 and a beta of 0.39. Stericycle has a 52-week low of $63.36 and a 52-week high of $63.99.
In other Stericycle news, Director Jack W. Schuler acquired 10,000 shares of the stock in a transaction dated Thursday, March 1st. The shares were purchased at an average price of $62.59 per share, for a total transaction of $625,900.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Thomas D. Brown sold 13,210 shares of the stock in a transaction that occurred on Wednesday, May 16th. The stock was sold at an average price of $63.37, for a total transaction of $837,117.70. Following the completion of the transaction, the director now owns 14,705 shares in the company, valued at approximately $931,855.85. The disclosure for this sale can be found here. 3.50% of the stock is owned by corporate insiders.
Several large investors have recently modified their holdings of SRCL. Zions Bancorporation bought a new stake in Stericycle during the 1st quarter worth approximately $122,000. Federated Investors Inc. PA raised its stake in Stericycle by 129.5% during the 1st quarter. Federated Investors Inc. PA now owns 2,088 shares of the business services provider’s stock worth $122,000 after acquiring an additional 1,178 shares during the period. Fuller & Thaler Asset Management Inc. raised its stake in Stericycle by 500.0% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 3,000 shares of the business services provider’s stock worth $204,000 after acquiring an additional 2,500 shares during the period. Balter Liquid Alternatives LLC bought a new stake in Stericycle during the 4th quarter worth approximately $206,000. Finally, Roberts Glore & Co. Inc. IL bought a new stake in Stericycle during the 4th quarter worth approximately $210,000. Hedge funds and other institutional investors own 95.63% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.